“clinical-trial” Archives

in
Entry Author Date Location
Biogen’s AdComm Meeting Will Test FDA’s “Substantial Evidence” Flexibility 10/08/20 Boston
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program’s End 08/18/20 San Francisco
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test 07/14/20 San Diego
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Sarepta Eyes Key Test for Gene Therapy in Rare Muscular Dystrophy 06/08/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Deciphera Pharmaceuticals Wins Early FDA Nod for GI Cancer Treatment 05/15/20 Boston
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study 05/11/20 National
Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter 04/22/20 Boston
Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test 04/06/20 Detroit Ann Arbor
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff 02/10/20 Boston
United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial 02/03/20 National
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned 12/16/19 New York
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal 12/06/19 National
Startup X-37 Raises $14.5M to Expand on AI-Powered Drug Discovery 11/14/19 San Francisco
Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing 11/12/19 Texas
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Page 1 of 5 next page »